What conditions does Shenzhen Geno-Immune Medical Institute run trials for?

In our tracked recruiting trials, Shenzhen Geno-Immune Medical Institute sponsors trials for Melanoma, Prostate cancer, Breast Cancer.

Clinical trials sponsored by Shenzhen Geno-Immune Medical Institute

Recruiting trials

Conditions studied

Phase 1 6Phase 2 6

Condition	Trials
Melanoma	2
Prostate cancer	2
Breast Cancer	1
COPD	1
Chronic Obstructive Pulmonary Disease (COPD)	1
PSMA Positive Tumors or Tumor Tissues	1
Prostate Cancer Indications	1

Combination Immunotherapy Targeting Melanoma
NCT06739226 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
Multi-4SCAR-T Therapy Targeting Breast Cancer
NCT04430595 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
NG2 and DLL3 CAR-T Cells Targeting Melanoma
NCT07193966 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
PSMA-specific CAR-T Cell Therapy
NCT04429451 · Phase: Phase 1, Phase 2 · Ages: 1 Year to 75 Years · Sex: All (male and female) · 1 location
Prostate Cancer Vaccines
NCT07068555 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
cfMSC Stem Cell Therapy Targeting COPD
NCT07477600 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location

Shenzhen Geno-Immune Medical Institute is the lead sponsor of 6 recruiting trials.

No. For the full record, search ClinicalTrials.gov.